» Articles » PMID: 21821913

IgE Stimulates Human and Mouse Arterial Cell Apoptosis and Cytokine Expression and Promotes Atherogenesis in Apoe-/- Mice

Abstract

IgE has a key role in the pathogenesis of allergic responses through its ability to activate mast cells via the receptor FcεR1. In addition to mast cells, many cell types implicated in atherogenesis express FcεR1, but whether IgE has a role in this disease has not been determined. Here, we demonstrate that serum IgE levels are elevated in patients with myocardial infarction or unstable angina pectoris. We found that IgE and the FcεR1 subunit FcεR1α were present in human atherosclerotic lesions and that they localized particularly to macrophage-rich areas. In mice, absence of FcεR1α reduced inflammation and apoptosis in atherosclerotic plaques and reduced the burden of disease. In cultured macrophages, the presence of TLR4 was required for FcεR1 activity. IgE stimulated the interaction between FcεR1 and TLR4, thereby inducing macrophage signal transduction, inflammatory molecule expression, and apoptosis. These IgE activities were reduced in the absence of FcεR1 or TLR4. Furthermore, IgE activated macrophages by enhancing Na+/H+ exchanger 1 (NHE1) activity. Inactivation of NHE1 blocked IgE-induced macrophage production of inflammatory molecules and apoptosis. Cultured human aortic SMCs (HuSMCs) and ECs also exhibited IgE-induced signal transduction, cytokine expression, and apoptosis. In human atherosclerotic lesions, SMCs and ECs colocalized with IgE and TUNEL staining. This study reveals what we believe to be several previously unrecognized IgE activities that affect arterial cell biology and likely other IgE-associated pathologies in human diseases.

Citing Articles

Clinical significance of very high IgE levels (≥1000 IU/mL): Population-based study of 118,211 adults.

Nemet S, Elbirt D, Cohen R, Mahlab-Guri K, Bezalel-Rosenberg S, Asher I J Allergy Clin Immunol Glob. 2025; 4(2):100403.

PMID: 39931077 PMC: 11808720. DOI: 10.1016/j.jacig.2025.100403.


Inhibition of immunoglobulin E attenuates pulmonary hypertension.

Shu T, Liu Y, Zhou Y, Zhou Z, Li B, Xing Y Nat Cardiovasc Res. 2024; 1(7):665-678.

PMID: 39196237 DOI: 10.1038/s44161-022-00095-9.


Atherosclerosis antigens as targets for immunotherapy.

Raposo-Gutierrez I, Rodriguez-Ronchel A, Ramiro A Nat Cardiovasc Res. 2024; 2(12):1129-1147.

PMID: 39196152 DOI: 10.1038/s44161-023-00376-x.


Allergic asthma is a risk factor for human cardiovascular diseases.

Guo J, Zhang Y, Liu T, Levy B, Libby P, Shi G Nat Cardiovasc Res. 2024; 1(5):417-430.

PMID: 39195946 DOI: 10.1038/s44161-022-00067-z.


B cells and atherosclerosis: A HIV perspective.

Obare L, Bonami R, Doran A, Wanjalla C J Cell Physiol. 2024; 239(6):e31270.

PMID: 38651687 PMC: 11209796. DOI: 10.1002/jcp.31270.


References
1.
Le T, Tversky J, Chichester K, Bieneman A, Huang S, Wood R . Interferons modulate Fc epsilon RI-dependent production of autoregulatory IL-10 by circulating human monocytoid dendritic cells. J Allergy Clin Immunol. 2008; 123(1):217-23. PMC: 2674243. DOI: 10.1016/j.jaci.2008.09.013. View

2.
Geng Y, Wu Q, Muszynski M, Hansson G, Libby P . Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol. 1996; 16(1):19-27. DOI: 10.1161/01.atv.16.1.19. View

3.
Naghavi M, John R, Naguib S, Siadaty M, Grasu R, Kurian K . pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque. Atherosclerosis. 2002; 164(1):27-35. DOI: 10.1016/s0021-9150(02)00018-7. View

4.
Takenaka H, Ushio H, Niyonsaba F, Jayawardana S, Hajime S, Ikeda S . Synergistic augmentation of inflammatory cytokine productions from murine mast cells by monomeric IgE and toll-like receptor ligands. Biochem Biophys Res Commun. 2009; 391(1):471-6. DOI: 10.1016/j.bbrc.2009.11.082. View

5.
Laukkanen J, Lehtolainen P, Gough P, Greaves D, Gordon S, Yla-Herttuala S . Adenovirus-mediated gene transfer of a secreted form of human macrophage scavenger receptor inhibits modified low-density lipoprotein degradation and foam-cell formation in macrophages. Circulation. 2000; 101(10):1091-6. DOI: 10.1161/01.cir.101.10.1091. View